P.384 Phase 1 study of intra-arterial hepatic (IAH) delivery of doxorubicin-transdrug® (DT) for patients with advanced hepatocellular carcinoma (HCC)
P. Merle, S. Si Ahmed, F. Habersetzer, A. Abergel, J. Taieb, L. Bonyhay, D. Costantini, J. Dufour-Lamartinie, C. TrépoVolume:
36
Year:
2006
Language:
english
DOI:
10.1016/s1386-6532(06)80558-5
File:
PDF, 146 KB
english, 2006